Related Experiment Video

Updated: Aug 6, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
14:25

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans

Published on: September 21, 2019

Not too excited? Thank your endocannabinoids

Bradley E Alger1

  • 1Department of Physiology, Program in Neuroscience, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, 21201, USA.

Neuron
|August 16, 2006
PubMed

Insights

Endocannabinoids offer neuroprotection, but the mechanism is unclear. This study reveals cannabinoid CB1 receptors on hippocampal glutamatergic nerve terminals mediate protection against seizures and cell death.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Endocannabinoids are endogenous compounds with neuroprotective potential.
  • The precise mechanisms underlying endocannabinoid-mediated neuroprotection remain largely unknown.
  • Cannabinoid receptor 1 (CB1) is a key target for these effects.

Discussion:

  • This study investigates the role of CB1 receptors in neuroprotection using conditional knockout mice.
  • Localized viral targeting was employed to achieve specific genetic modifications.
  • The research focuses on the impact of CB1 receptor function in the hippocampus.

Key Insights:

  • Cannabinoid CB1 receptors (CB1Rs) on hippocampal glutamatergic nerve terminals confer protection against kainic acid-induced seizures.
  • CB1Rs are crucial for preventing excitotoxicity and neuronal death in the hippocampus.
  • This finding elucidates a specific cellular and molecular pathway for endocannabinoid neuroprotection.

Outlook:

  • Further research can explore therapeutic strategies targeting CB1Rs for epilepsy and neurodegenerative diseases.
  • Understanding the precise downstream signaling of CB1Rs in this context is warranted.
  • Investigating the role of CB1Rs in other brain regions and seizure models is a future direction.

More Related Videos

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...